In this episode, Jason is joined by Bobby Schmidt, Co-Head of Global Healthcare at Carlyle, for a discussion about durable growth trends across healthcare, life sciences, and medtech, and what the record-setting Medline IPO may signal for exits in 2026.
Our research disclosure is available at https://www.carlyle.com/notices-and-disclaimers.
Episode
•
September 27, 2024
In this episode, Jeff Nedelman, Carlyle’s Head of Global Distribution, joins Jason for a discussion about the Fed’s rate cut, its potential impact on...
00:29:49
Episode 7
•
October 31, 2022
Jason Thomas, Head of Global Research at Carlyle, discusses the increase in forward interest rates and the third quarter GDP data in the US....
00:14:30
Episode
•
September 18, 2025
In this episode, Jason is joined by Brian Bernasek and Steve Wise, Co-Heads of Americas Corporate Private Equity at Carlyle, who share what they...
00:22:44
